Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Marc D Lemoine

University Name

Germany

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Cardiology

70%

Anesthesiology

40%

Cardiac Ablation

60%

Interventional Medicine

40%

Atrial Fibrillation

40%

Calcium Signaling

20%

Cardiogenic Shock

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles20

Short-term benefit of early rhythm control for atrial fibrillation: the EAST-AFNET 4 trial

Article Link

Year:

2025

Prevalence of Heart Failure With Preserved Ejection Fraction in Patients Referred for Atrial Fibrillation Ablation

Article Link

Year:

2025

Comparison of cardiac troponin assays reveals assay-specific sensitivities in a clinical model of very acute myocardial injury

Article Link

Year:

2025

Asymptomatic atrial fibrillation: the tasks ahead

Article Link

Year:

2025

Improving antiarrhythmic therapy for patients with atrial fibrillation using common genetic variants

Article Link

Year:

2025

Safety and efficacy of long-term sodium channel blocker therapy for early rhythm control: the EAST-AFNET 4 trial

Article Link

Year:

2024

General anaesthesia and deep sedation for monopolar pulsed field ablation using a lattice-tip catheter combined with a novel three-dimensional mapping system

Article Link

Year:

2024

Pulmonary vein reconnection and repeat ablation characteristics following cryoballoon‐compared to radiofrequency‐based pulmonary vein isolation

Article Link

Year:

2024

Pulsed-field- vs. cryoballoon-based pulmonary vein isolation: lessons from repeat procedures

Article Link

Year:

2024

Atrial fibrillation in the young: consider heritable conditions like short QT syndrome

Article Link

Year:

2024

Acute lesion extension following pulmonary vein isolation with two novel single shot devices: Pulsed field ablation versus multielectrode radiofrequency balloon

Article Link

Year:

2023

Nonthermal Point-by-Point Pulmonary Vein Isolation Using a Novel Pulsed Field Ablation System

Article Link

Year:

2023

Pulsed-field ablation-based pulmonary vein isolation: acute safety, efficacy and short-term follow-up in a multi-center real world scenario

Article Link

Year:

2023

Pulmonary Vein Isolation by Pulsed-field Ablation Induces Less Neurocardiac Damage Than Cryoballoon Ablation

Article Link

Year:

2023

PITX2 Knockout Induces Key Findings of Electrical Remodeling as Seen in Persistent Atrial Fibrillation

Article Link

Year:

2023

<i>ACTN2</i> Mutant Causes Proteopathy in Human iPSC-Derived Cardiomyocytes

Article Link

Year:

2022

Regulation of APD and Force by the Na+/Ca2+ Exchanger in Human-Induced Pluripotent Stem Cell-Derived Engineered Heart Tissue

Article Link

Year:

2022

The established and the challenger: A direct comparison of current cryoballoon technologies for pulmonary vein isolation

Article Link

Year:

2022

Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?

Article Link

Year:

2021

Human Engineered Heart Tissue Patches Remuscularize the Injured Heart in a Dose-Dependent Manner.

Article Link

Year:

2021

Collaborators10

Torsten Christ

University Medical Center Hamburg-Eppendorf

GERMANY

Harry Crijns

Maastricht University Medical Centre

NETHERLANDS

Lucie Carrier

University Medical Center Hamburg-Eppendorf

GERMANY

Paulus Kirchhof

University of Birmingham

UNITED KINGDOM

Moritz Nies

University Heart and Vascular Center

GERMANY

Christina Magnussen

University Heart and Vascular Center Hamburg

GERMANY

Edzard Schwedhelm

University Medical Center Hamburg-Eppendorf

GERMANY

Andreas Metzner

GERMANY

Jussi Koivumäki

University of Tampere

FINLAND

Elke Hammer

University Medicine Greifswald

GERMANY

How do I reach out?

Meet Kite AI